Worldwide Clinical Trials Partners With Every Cure

Worldwide Clinical Trials (Worldwide) has partnered with Every Cure.

Through this new partnership, Worldwide will serve as Every Cure’s clinical trial and drug development partner. The CRO will use its clinical development and rare disease know-how to assist in identifying links between rare diseases and generic drugs on the market—all facilitated through the nonprofit’s open-source database of drug-repurposing opportunities.

Every Cure was co-founded by Dr. David Fajgenbaum, Dr. Grant Mitchell, and Tracey Sikora in 2022.

Reference

Worldwide Clinical Trials Partners with Every Cure to Accelerate Discovery of Treatments for Rare Disease Patients. (2023, May 11). Business Wire.